Chemicalinfo Chemlink Pharm-Chem Net

Brazil is building up to capture a significantly greater portion of the global pharmaceutical market in the near future.....

Bortezomib, a specific and selective inhibitor of the 26S proteasome with antitumor activity against a wide range of malignancies, has been approved for the treatment of relapsed or refractory multiple myeloma and other cancers. Recently, bortezomib ...